FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

36630811000001108: Insulin glargine + Lixisenatide (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Feb 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
112483301000001110 Insulin glargine + Lixisenatide (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
112483401000001119 Insulin glargine + Lixisenatide en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


4 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Insulin glargine + Lixisenatide Is a Virtual therapeutic moiety true Inferred relationship Existential restriction modifier
Insulin glargine + Lixisenatide Is a Product containing insulin glargine false Inferred relationship Existential restriction modifier
Insulin glargine + Lixisenatide Is a Product containing lixisenatide true Inferred relationship Existential restriction modifier
Insulin glargine + Lixisenatide Has active ingredient Insulin glargine true Inferred relationship Existential restriction modifier
Insulin glargine + Lixisenatide Has active ingredient Lixisenatide true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Insulin glargine 100units/ml / Lixisenatide 33micrograms/ml solution for injection 3ml pre-filled disposable devices Is a True Insulin glargine + Lixisenatide Inferred relationship Existential restriction modifier
Insulin glargine 100units/ml / Lixisenatide 50micrograms/ml solution for injection 3ml pre-filled disposable devices Is a True Insulin glargine + Lixisenatide Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start